Related Experiment Video
Updated: Aug 5, 2025

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Booster Vaccination in Infancy Reduces the Incidence of Occult HBV Infection in Maternal HBsAg-positive Children
Yi Li1,2, Lili Li1, Yarong Song1
1Department of Microbiology & Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
Insights
A hepatitis B vaccine (HepB) booster in infancy significantly reduced occult hepatitis B infection (OBI) in children born to mothers with hepatitis B surface antigen. This booster dose improved HBV DNA negative conversion rates by age eight.
Area of Science:
- Hepatology
- Immunology
- Pediatrics
Background:
- Occult hepatitis B infection (OBI) in children is linked to immune responses after hepatitis B vaccine (HepB) administration.
- The impact of HepB boosters on OBI in children is not well-documented.
Purpose of the Study:
- To investigate the effect of a booster HepB dose on OBI incidence in children born to HBsAg-positive mothers.
- To analyze the long-term outcomes of OBI in relation to vaccination status.
Main Methods:
- A cohort of 236 children born to HBsAg-positive mothers were followed until age 8.
- Children were categorized into a booster group (100 received HepB between 1-3 years) and a non-booster group (136).
- Serial follow-up data and maternal baseline data were collected for comparative analysis.
Main Results:
- OBI incidence fluctuated dynamically, with varying rates observed throughout the follow-up period.
- At 8 years, the booster group showed a significantly higher HBV DNA negative conversion rate (57.89%) compared to the non-booster group (30.51%, p=0.032).
- For children without OBI at 7 months, the booster group had a significantly lower OBI incidence (25.64%) than the non-booster group (67.74%, p<0.001).
Conclusions:
- Maternal HBsAg positivity is associated with a high incidence of OBI in children.
- Serum HBV DNA levels in children with OBI are intermittently positive and at low levels.
- A booster HepB dose in infancy is effective in reducing OBI incidence in children born to HBsAg-positive mothers.
Background And Aims:
Occult HBV infection (OBI) in children has proven to be associated with their immune response to hepatitis B vaccine (HepB). This study aimed to investigate the effect of a booster HepB on OBI, which is rarely investigated.
Methods:
This study enrolled 236 maternal HBsAg-positive children who were followed up annually until 8 years of age and were hepatitis B surface antigen (HBsAg) negative. Of those 100 received a booster HepB between 1 and 3 years of age (booster group), and 136 were never boosted (non-booster group). Serial follow-up data of children and baseline data of their mothers were collected and between-group differences were analyzed.
Results:
The incidence of OBI varied dynamically during follow-up, with 37.14% (78/210), 19.09% (42/220), 20.85% (44/211), 31.61% (61/193), 8.65% (18/208) and 12.71% (30/236) at 7 months, 1, 2, 3, 4, and 8 years of age. At 8 years of age, the negative conversion rate of HBV DNA in the booster group was significantly higher than that in non-booster group [57.89% (11/19) vs. 30.51% (18/59), p=0.032]. For children without OBI at 7 months old, the incidence of OBI in booster group was significantly lower than that in non-booster group [25.64% (10/39) vs. 67.74% (63/93), p<0.001].
Conclusions:
The incidence of OBI in maternal HBsAg-positive children was high, serum HBV DNA in children with OBI was intermittently positive at low levels, and a booster HepB in infancy reduced the incidence of OBI in children with HBsAg-positive mothers.
More Related Videos
11:28Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
Published on: March 13, 2015
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
Related Concept Videos
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Vaccinations
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Active versus Passive Immunity
Active Immunity
Active immunity refers to the resistance one develops...
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Rh Blood Group